Shanghai Fosun Pharmaceutical (Group) Co Ltd 2021 SR
The report highlights Fosun Pharma's 2021 sustainability efforts, focusing on innovation-driven healthcare and the launch of products like the Yi Kai Da® CAR-T therapy and the COMIRNATY® mRNA vaccine. The company achieved a revenue of RMB 39,005 million and invested RMB 4,975 million in R&D. Environmental milestones include a 15.5% reduction in carbon emission intensity and the purchase of 26.59 million kWh of green power. Social initiatives featured the 'Fosun Care 121' fund and the 'Rural Revitalization Health Demonstration Project,' supporting primary healthcare. The report also details a comprehensive risk management system and adherence to GRI and HKEX ESG standards.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: SR
Pages: 131
Back to company
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Corporate Social Responsibility Report
The report highlights Fosun Pharma's 2021 sustainability efforts, focusing on innovation-driven healthcare and the launch of products like the Yi Kai Da® CAR-T therapy and the COMIRNATY® mRNA vaccine. The company achieved a revenue of RMB 39,005 million and invested RMB 4,975 million in R&D. Environmental milestones include a 15.5% reduction in carbon emission intensity and the purchase of 26.59 million kWh of green power. Social initiatives featured the 'Fosun Care 121' fund and the 'Rural Revitalization Health Demonstration Project,' supporting primary healthcare. The report also details a comprehensive risk management system and adherence to GRI and HKEX ESG standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees